Amgen Inc Sotorasib Update Call from ESMO Virtual Congress 2020 Transcript
Good afternoon. My name is Annie, and I will be your conference facilitator today for Amgen's conference call in conjunction with the ESMO 2020 Virtual Congress. (Operator Instructions)
I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.
Okay. Great. Thank you, Annie, and good afternoon, everybody. Good morning for those of us on the West Coast. My apologies for the slightly delayed start this morning. Delighted you could join us today, and hopefully, you can join us again tomorrow.
We presented some important data this morning in the virtual scientific session of ESMO on, sotorasib, also known as AMG 510, which, as you know, is a first-in-class inhibitor of KRAS G12C, and this is advancing rapidly through clinical development. In addition, we are also presenting data tomorrow on our extended half-life BiTE AMG 160 that targets PSMA or prostate-specific membrane antigen. And in conjunction with that presentation, we'll conduct another call tomorrow at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
